The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 39% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 125%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (2 analysts) rates it buy, with a mean price target of $14.
Silvercorp Metals Inc.
SVM · NYSE American · USD · Market cap $2.8B
PASS · Titan EthicalAt the last full screen
2026-09-07
Screened 2026-09-07 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
Silvercorp Metals Inc. holds its Markup at $12.48. Consolidating, no directional conviction, held for 43 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 43 days |
| Price at the screen | $12.48 |
| Valuation | 113.45 trailing · 8.04 forward price to earnings |
| Values screen | PASS |
| Beta | 2.04 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 4.35% | Below 33% | Interest-bearing debt is just 4.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 17.54% | Below 33% | Cash held in interest-bearing accounts and securities is 17.5% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-07 screen. The gold marker is the market price at the same screen. A 11.7% margin of safety to the base estimate.
Third-party analyst targets: 2 covering, consensus None. The average target sits +18% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-07 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCheap miners at five times earnings often trap value
Picture a silver miner posting 96% revenue growth while still losing money on every ounce sold. Silvercorp shows exactly that mix, with a forward multiple of 5.3 times earnings and a claimed 35% margin of safety to fair value. Yet the business carries a weak moat, returns on equity of just 3%, and a negative profit margin, all inside an industry where earnings peak and trough with metal prices.
The low multiple and analyst target near 14 dollars make the shares appear undervalued on paper. Ethical screens clear it without issue. In cyclical metals, however, that combination usually signals peak earnings rather than a bargain, and the numbers here offer little evidence the next downswing has been priced in.
High revenue growth can vanish quickly when prices fall, and thin returns leave little cushion. The absence of any durable advantage means the company will likely compete away any windfall the moment conditions normalise. Analysis, not advice.
| Forward P/E | 8.0xcheap for a company growing this fast |
| Trailing P/E | 113.5xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.11 |
| EPS, forward | 1.55 |
| Revenue growth | +70.5%growing very fast |
| Profit margin | 6.3%thin but positive margins |
| Return on equity | 8.1%a modest return on shareholder capital |
| FCF yield | 1.19% |
| Dividend yield | 20.00% |
| Debt to equity | 0.10minimal debt: a conservative balance sheet |
| Current ratio | 3.51comfortably covers its short-term bills |
| Beta | 2.04much more volatile than the market |
| Short interest, float | 0.13% |
| 52-week range | 4.81 - 15.77 |
| Moat | WEAK |
| Market cap | $2.8B |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSVM trades on NYSE American. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 39% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 125%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (2 analysts) rates it buy, with a mean price target of $14.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-21 | Liu (Yikang) | Director of Issuer | 2,334 | $8,661 | |
| 2026-04-21 | Liu (Yikang) | Director of Issuer | 4,333 | $13,986 | |
| 2026-04-21 | Liu (Yikang) | Director of Issuer | 7,334 | $87,281 | |
| 2026-04-15 | Lekich (Peter) | Senior Officer of Issuer | 7,499 | · | |
| 2026-04-14 | Cai (Hongyu) | Director of Issuer | 8,333 | · | |
| 2026-04-14 | Lekich (Peter) | Senior Officer of Issuer | 2,050 | $25,317 | |
| 2026-04-14 | Liu (Yikang) | Director of Issuer | 12,500 | · | |
| 2026-04-14 | Wang (Winnie) | Senior Officer of Issuer | 834 | · | |
| 2026-04-09 | Katusa (Marina A.) | Director of Issuer | 12,500 | · | |
| 2026-03-10 | Lekich (Peter) | Senior Officer of Issuer | 4,200 | $52,117 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $14.73 | -35.0% | $0.01 | $651 | -34.9% |
| 2 months | $11.49 | -16.6% | $0.01 | $835 | -16.5% |
| 3 months | $11.53 | -16.9% | $0.01 | $832 | -16.8% |
| 6 months | $8.53 | +12.3% | $0.01 | $1,125 | +12.5% |
| 1 year | $4.26 | +125.1% | $0.01 | $2,254 | +125.4% |
| 2 years | $3.58 | +167.5% | $0.04 | $2,686 | +168.6% |
| 3 years | $2.99 | +220.5% | $0.07 | $3,227 | +222.7% |
| 5 years | $6.13 | +56.2% | $0.12 | $1,581 | +58.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SVM does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.